2025
SJR Q1
JCR Q2 · 3,4
32 matched articles
SCIE
Journal detail
Molecular and Cellular Endocrinology
- Publisher
- Elsevier Ireland Ltd
- Country
- Ireland · Western Europe
- Type
- journal
- ISSN
-
0303720718728057
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,232
- Quartile Q1
- H-Index 181
- Cites/doc 3,46
- Docs (3y) 487
- Cites (3y) 2.167
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,4
- 5Y JIF 4,3
- JCI 0,74
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q1
- Endocrinology Q2
- Molecular Biology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
WoS categories
- Cell Biology | Endocrinology & Metabolism
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,232 | 3,4 | 4,3 | 0,74 | Q2 | 181 |
| 2024 | Q1 | Q2 | 1,198 | 3,6 | 3,8 | 0,79 | Q2 | 174 |
| 2023 | Q1 | Q2 | 1,13 | 3,8 | 3,7 | 0,78 | Q2 | 174 |
| 2022 | Q2 | Q2 | 1,009 | 4,1 | 4,1 | 0,75 | Q2 | 174 |
| 2021 | Q2 | Q2 | 1,039 | 4,4 | 4,5 | 0,74 | Q2 | 174 |
| 2020 | Q1 | Q2 | 1,296 | 4,1 | 4,2 | 0,84 | Q2 | 174 |
| 2019 | Q1 | Q2 | 1,305 | 3,9 | 3,8 | 0,91 | Q2 | 174 |
| 2018 | — | Q2 | — | 3,7 | 3,8 | 0,89 | Q2 | — |
| 2017 | Q1 | Q2 | 1,629 | 3,6 | 4 | 0,84 | Q2 | 174 |
| 2016 | Q1 | Q2 | 1,779 | 3,8 | 3,8 | — | — | 174 |
| 2015 | Q1 | Q2 | 2,14 | 3,9 | 4 | — | — | 174 |
| 2014 | Q1 | Q1 | 1,963 | 4,4 | 4,1 | — | — | 174 |
| 2013 | Q1 | Q1 | 2,085 | 4,2 | 4,2 | — | — | 174 |
| 2012 | Q1 | Q2 | 1,668 | 4 | 3,8 | — | — | 174 |
| 2011 | Q1 | Q2 | 1,794 | 4,2 | 3,7 | — | — | 174 |
| 2010 | Q1 | Q2 | 1,648 | 4,1 | 3,7 | — | — | 174 |
| 2009 | — | Q2 | — | 3,5 | 3,5 | — | — | — |
| 2008 | — | Q2 | — | 3,6 | 3,2 | — | — | — |
| 2007 | — | Q2 | — | 3 | 3 | — | — | — |
| 2006 | — | Q2 | — | 2,9 | — | — | — | — |
| 2005 | — | Q2 | — | 2,8 | — | — | — | — |
| 2004 | — | Q2 | — | 2,6 | — | — | — | — |
| 2003 | — | Q2 | — | 2,6 | — | — | — | — |
| 2002 | — | Q2 | — | 2,7 | — | — | — | — |
| 2001 | — | Q2 | — | 2,4 | — | — | — | — |
| 2000 | — | Q2 | — | 2,4 | — | — | — | — |
| 1999 | — | Q2 | — | 2,1 | — | — | — | — |
| 1998 | — | Q2 | — | 2,3 | — | — | — | — |
| 1997 | — | Q2 | — | 2,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q3 | Q2 | 124/207 |
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 95/198 |
| 2024 | CELL BIOLOGY | SCIE | Q2 | Q2 | 100/204 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 66/193 |
| 2023 | CELL BIOLOGY | SCIE | Q2 | Q2 | 96/205 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 59/186 |
| 2022 | CELL BIOLOGY | SCIE | Q3 | Q2 | 100/191 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 56/145 |
| 2021 | CELL BIOLOGY | SCIE | Q3 | Q2 | 108/195 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 66/146 |
| 2020 | CELL BIOLOGY | SCIE | Q3 | Q2 | 115/195 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 70/146 |
| 2019 | CELL BIOLOGY | SCIE | Q2 | Q2 | 88/195 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 42/143 |
| 2018 | CELL BIOLOGY | SCIE | Q2 | Q2 | 88/193 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 48/145 |
| 2017 | CELL BIOLOGY | SCIE | Q2 | Q2 | 85/190 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 50/142 |
| 2016 | CELL BIOLOGY | SCIE | Q2 | — | 79/190 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 42/138 |
| 2015 | CELL BIOLOGY | SCIE | Q2 | — | 72/187 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 34/133 |
| 2014 | CELL BIOLOGY | SCIE | Q2 | — | 62/184 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 30/128 |
| 2013 | CELL BIOLOGY | SCIE | Q2 | — | 68/185 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 28/124 |
| 2012 | CELL BIOLOGY | SCIE | Q2 | — | 70/185 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 33/122 |
| 2011 | CELL BIOLOGY | SCIE | Q2 | — | 64/181 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 32/122 |
| 2010 | CELL BIOLOGY | SCIE | Q2 | — | 69/178 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 33/116 |
| 2009 | CELL BIOLOGY | SCIE | Q2 | — | 76/162 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 38/105 |
| 2008 | CELL BIOLOGY | SCIE | Q2 | — | 66/157 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 32/93 |
| 2007 | CELL BIOLOGY | SCIE | Q3 | — | 80/156 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 37/92 |
| 2006 | CELL BIOLOGY | SCIE | Q3 | — | 79/156 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 35/93 |
| 2005 | CELL BIOLOGY | SCIE | Q2 | — | 67/153 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 35/89 |
| 2004 | CELL BIOLOGY | SCIE | Q2 | — | 73/155 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 36/87 |
| 2003 | CELL BIOLOGY | SCIE | Q2 | — | 68/156 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 37/88 |
| 2002 | CELL BIOLOGY | SCIE | Q2 | — | 62/153 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 29/88 |
| 2001 | CELL BIOLOGY | SCIE | Q2 | — | 65/147 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 35/90 |
| 2000 | CELL BIOLOGY | SCIE | Q2 | — | 65/147 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 36/89 |
| 1999 | CELL BIOLOGY | SCIE | Q2 | — | 64/141 |
| 1999 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 34/85 |
| 1998 | CELL BIOLOGY | SCIE | Q2 | — | 50/139 |
| 1998 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 24/83 |
| 1997 | CELL BIOLOGY | SCIE | Q2 | — | 51/130 |
| 1997 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 27/81 |